Jan-Erik Messling

Before joining the Lundbeckfonden BioCapital team, Jan-Erik worked as a management consultant for the Boston Consulting Group focusing on the Biopharma and Med Tech sector. Prior to that, he worked in several academic research labs in Denmark and Germany focusing on cancer and stem cell research.

Jan-Erik holds an MSc in Biological Sciences with a research focus in Genetics and Cell Biology from the University of Cologne and a PhD in Molecular Mechanisms of Disease from Copenhagen University.

 Board Observer: Folium Science, IO Biotech